137 related articles for article (PubMed ID: 34180584)
21. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
22. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
23. Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer.
De Wever W; Vankan Y; Stroobants S; Verschakelen J
Eur Respir J; 2007 May; 29(5):995-1002. PubMed ID: 17331966
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of FDG PET/CT in the evaluation of solitary pulmonary lesions - own experience.
Opoka L; Kunikowska J; Podgajny Z; Szołkowska M; Błasińska-Przerwa K; Burakowska B; Oniszh K; Rudziński P; Bestry I; Roszkowski-Śliż K
Pneumonol Alergol Pol; 2014; 82(3):198-205. PubMed ID: 24793147
[TBL] [Abstract][Full Text] [Related]
25. Differentiating solitary pulmonary metastases in patients with extrapulmonary neoplasmas using FDG-PET.
Hsu WH; Hsu NY; Shen YY; Yen RF; Kao CH
Cancer Invest; 2003; 21(1):47-52. PubMed ID: 12643009
[TBL] [Abstract][Full Text] [Related]
26. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
27. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules.
Bryant AS; Cerfolio RJ
Ann Thorac Surg; 2006 Sep; 82(3):1016-20. PubMed ID: 16928527
[TBL] [Abstract][Full Text] [Related]
28. Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy.
Conrad GR; Sinha P
Nucl Med Commun; 2003 Nov; 24(11):1129-37. PubMed ID: 14569166
[TBL] [Abstract][Full Text] [Related]
29. Incidental focal FDG uptake in the parotid glands on PET/CT in patients with head and neck malignancy.
Seo YL; Yoon DY; Baek S; Lim KJ; Yun EJ; Cho YK; Bae WJ; Chung EJ; Kwon KH
Eur Radiol; 2015 Jan; 25(1):171-7. PubMed ID: 25182627
[TBL] [Abstract][Full Text] [Related]
30. The role of extended cervical mediastinoscopy in staging of non-small cell lung cancer of the left lung and a comparison with integrated positron emission tomography and computed tomography: does integrated positron emission tomography and computed tomography reduce the need for invasive procedures?
Metin M; Citak N; Sayar A; Pekcolaklar A; Melek H; Kök A; Gurses A
J Thorac Oncol; 2011 Oct; 6(10):1713-9. PubMed ID: 21716145
[TBL] [Abstract][Full Text] [Related]
31. Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis.
Pastorino U; Veronesi G; Landoni C; Leon M; Picchio M; Solli PG; Leo F; Spaggiari L; Pelosi G; Bellomi M; Fazio F
J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1906-10. PubMed ID: 14688704
[TBL] [Abstract][Full Text] [Related]
32. Characterization of pulmonary lesions in patients with suspected lung cancer: computed tomography versus [¹⁸F] fluorodeoxyglucose-positron emission tomography/computed tomography.
Harders SW; Madsen HH; Hjorthaug K; Arveschoug AK; Rasmussen TR; Meldgaard P; Andersen JB; Pilegaard HK; Hager H; Rehling M; Rasmussen F
Cancer Imaging; 2012 Oct; 12(3):437-46. PubMed ID: 23092816
[TBL] [Abstract][Full Text] [Related]
33. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
[TBL] [Abstract][Full Text] [Related]
34. Biopsy findings in PET/CT-positive lung lesions in a community hospital.
Lobrano MB; Hayman E; Dekelbaum M; Campeau R
J La State Med Soc; 2005; 157(6):319-24. PubMed ID: 16579344
[TBL] [Abstract][Full Text] [Related]
35. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer.
Reed CE; Harpole DH; Posther KE; Woolson SL; Downey RJ; Meyers BF; Heelan RT; MacApinlac HA; Jung SH; Silvestri GA; Siegel BA; Rusch VW;
J Thorac Cardiovasc Surg; 2003 Dec; 126(6):1943-51. PubMed ID: 14688710
[TBL] [Abstract][Full Text] [Related]
36.
Zhu L; Bian H; Yang L; Liu J; Chen W; Li X; Wang J; Song X; Dai D; Ye Z; Xu W; Yu X
Thorac Cancer; 2019 May; 10(5):1086-1095. PubMed ID: 30900387
[TBL] [Abstract][Full Text] [Related]
37. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN
J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005
[TBL] [Abstract][Full Text] [Related]
38. Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer.
Mak RH; Digumarthy SR; Muzikansky A; Engelman JA; Shepard JA; Choi NC; Sequist LV
Oncologist; 2011; 16(3):319-26. PubMed ID: 21339258
[TBL] [Abstract][Full Text] [Related]
39. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
40. Positron emission tomography/computed tomography and lymphovascular invasion predict recurrence in stage I lung cancers.
Shiono S; Abiko M; Sato T
J Thorac Oncol; 2011 Jan; 6(1):43-7. PubMed ID: 21079522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
